D
Exact Sciences Corporation EXAS
$45.46 -$0.14-0.31% NASDAQ
Recommendation
Prev Close
$45.60
Volume
1,093,730
Avg Vol (90D)
2,282,295
Market Cap
$8.47B
Dividend & Yield
--
52-Week Range
$39.97 - $72.83
P/E (TTM)
--
EPS (TTM)
-$5.57
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Exact Sciences Co. (NASDAQ:EXAS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
4/25/2025 - Ticker Report
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
4/24/2025 - Zacks Investment Research
Exact Sciences (EXAS): Among Billionaire George Soros' Small-Cap Stocks with Huge Upside Potential
4/24/2025 - Yahoo! Finance: News
2 Reasons to Like EXAS (and 1 Not So Much)
4/24/2025 - StockStory Articles
Billionaire George Soros' 10 Small-Cap Stocks with Huge Upside Potential
4/23/2025 - Insider Monkey
Exact Sciences (NASDAQ:EXAS) Trading 5.7% Higher - Here's What Happened
4/23/2025 - MarketBeat
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
4/23/2025 - Zacks Investment Research
Rock Springs Capital Management LP Has $25.29 Million Stock Position in Exact Sciences Co. (NASDAQ:EXAS)
4/23/2025 - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Has $1.14 Million Position in Exact Sciences Co. (NASDAQ:EXAS)
4/23/2025 - Ticker Report
Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail's Optimistic
4/22/2025 - Stocktwits News Feed
Exact Sciences launches Oncodetect residual disease detector test
4/22/2025 - SeekingAlpha.com: All News
Exact Sciences (EXAS) Launches Oncodetect Test for Enhanced Cancer Care EXAS Stock News
4/22/2025 - GuruFocus
Exact Sciences launches the Oncodetect MRD test
4/22/2025 - TipRanks Financial Blog
Exact Sciences launches the Oncodetect MRD test
4/22/2025 - The Fly
Exact Sciences Launches the Oncodetect Molecular Residual Disease Test
4/22/2025 - Business Wire
Exact Sciences Co. (NASDAQ:EXAS) Shares Bought by Capital World Investors
4/22/2025 - MarketBeat
Altium Capital Management LLC Acquires Shares of 100,000 Exact Sciences Co. (NASDAQ:EXAS)
4/20/2025 - MarketBeat
Champlain Investment Partners LLC Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS)
4/19/2025 - MarketBeat
Wasatch Advisors LP Has $23.48 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS)
4/19/2025 - MarketBeat
Market Sentiment Around Loss-Making Exact Sciences Corporation (NASDAQ:EXAS)
4/18/2025 - Simply Wall St
Advisors Capital Management LLC Buys New Position in Exact Sciences Co. (NASDAQ:EXAS)
4/18/2025 - MarketBeat
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
4/17/2025 - Investor's Business Daily
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
4/15/2025 - StockStory Articles
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
4/14/2025 - Zacks Investment Research
Exact Sciences Corp (EXAS) Strengthens Evidence for Oncotype DX Test in Diverse Populations ...
4/14/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$2.76B
EBITDA (TTM)
$43.00M
EBIT (TTM)
-$171.86M
Net Income (TTM)
-$1.03B
Balance Sheet
Total Assets (Q)
$5.93B
Total Debt (Q)
$2.78B
Total Liabilities (Q)
$3.53B
Book Value Per Share (Q)
$12.94
Cash Flow
Cash from Operations (TTM)
$210.54M
Cash from Investing (TTM)
-$442.16M
Cash from Financing (TTM)
$231.87M
Net Change in Cash (TTM)
-$3.04M
Filings
Filing Date
Wednesday, February 19, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.80
7-Day Total Return
4.10%
30-Day Total Return
5.62%
60-Day Total Return
-17.18%
90-Day Total Return
-27.28%
Year to Date Total Return
-20.14%
1-Year Total Return
-22.67%
2-Year Total Return
-28.47%
3-Year Total Return
-27.43%
5-Year Total Return
-43.37%
52-week Low
Apr 08, 2025 - $39.97
52-week High
Nov 05, 2024 - $72.83
Valuation
Market Cap
$8.47B - Mid Cap
Enterprise Value
$10.21B
Price/Sales (TTM)
3.06
Price/Book (Q)
3.52
Dividends and Shares
Shares Outstanding
185.31M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.exactsciences.com
Phone Number
608 284 5700
Address
5505 Endeavor Lane
Madison, WI 53719
Country
United States
Year Founded
1995
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed